(2S,3S)-Oxirane-2,3-dicarboxylic acid: A privileged platform for probing human cysteine cathepsins

Schaschke N (2007)
JOURNAL OF BIOTECHNOLOGY 129(2): 308-315.

Journal Article | Published | English

No fulltext has been uploaded

Publishing Year
ISSN
PUB-ID

Cite this

Schaschke N. (2S,3S)-Oxirane-2,3-dicarboxylic acid: A privileged platform for probing human cysteine cathepsins. JOURNAL OF BIOTECHNOLOGY. 2007;129(2):308-315.
Schaschke, N. (2007). (2S,3S)-Oxirane-2,3-dicarboxylic acid: A privileged platform for probing human cysteine cathepsins. JOURNAL OF BIOTECHNOLOGY, 129(2), 308-315.
Schaschke, N. (2007). (2S,3S)-Oxirane-2,3-dicarboxylic acid: A privileged platform for probing human cysteine cathepsins. JOURNAL OF BIOTECHNOLOGY 129, 308-315.
Schaschke, N., 2007. (2S,3S)-Oxirane-2,3-dicarboxylic acid: A privileged platform for probing human cysteine cathepsins. JOURNAL OF BIOTECHNOLOGY, 129(2), p 308-315.
N. Schaschke, “(2S,3S)-Oxirane-2,3-dicarboxylic acid: A privileged platform for probing human cysteine cathepsins”, JOURNAL OF BIOTECHNOLOGY, vol. 129, 2007, pp. 308-315.
Schaschke, N.: (2S,3S)-Oxirane-2,3-dicarboxylic acid: A privileged platform for probing human cysteine cathepsins. JOURNAL OF BIOTECHNOLOGY. 129, 308-315 (2007).
Schaschke, Norbert. “(2S,3S)-Oxirane-2,3-dicarboxylic acid: A privileged platform for probing human cysteine cathepsins”. JOURNAL OF BIOTECHNOLOGY 129.2 (2007): 308-315.
This data publication is cited in the following publications:
This publication cites the following data publications:

2 Citations in Europe PMC

Data provided by Europe PubMed Central.

E-64c-hydrazide: a lead structure for the development of irreversible cathepsin C inhibitors.
Radzey H, Rethmeier M, Klimpel D, Grundhuber M, Sommerhoff CP, Schaschke N., ChemMedChem 8(8), 2013
PMID: 23780739

44 References

Data provided by Europe PubMed Central.

The lysosomal cysteine proteases.
McGrath ME., Annu Rev Biophys Biomol Struct 28(), 1999
PMID: 10410800
Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro.
Murata M, Miyashita S, Yokoo C, Tamai M, Hanada K, Hatayama K, Towatari T, Nikawa T, Katunuma N., FEBS Lett. 280(2), 1991
PMID: 2013328
A classical enzyme active center motif lacks catalytic competence until modulated electrostatically.
Pinitglang S, Watts AB, Patel M, Reid JD, Noble MA, Gul S, Bokth A, Naeem A, Patel H, Thomas EW, Sreedharan SK, Verma C, Brocklehurst K., Biochemistry 36(33), 1997
PMID: 9254592
Irreversible inhibitors of serine, cysteine, and threonine proteases.
Powers JC, Asgian JL, Ekici OD, James KE., Chem. Rev. 102(12), 2002
PMID: 12475205
MEROPS: the protease database
Rawlings, Nucl. Acid Res. 30(), 2002
Activity-based probes for the proteomic profiling of metalloproteases.
Saghatelian A, Jessani N, Joseph A, Humphrey M, Cravatt BF., Proc. Natl. Acad. Sci. U.S.A. 101(27), 2004
PMID: 15220480
Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitors.
Schaschke N, Assfalg-Machleidt I, Machleidt W, Moroder L., FEBS Lett. 421(1), 1998
PMID: 9462845
Epoxysuccinyl peptide-derived affinity labels for cathepsin B.
Schaschke N, Assfalg-Machleidt I, Lassleben T, Sommerhoff CP, Moroder L, Machleidt W., FEBS Lett. 482(1-2), 2000
PMID: 11018529
Epoxysuccinyl peptide-derived cathepsin B inhibitors: modulating membrane permeability by conjugation with the C-terminal heptapeptide segment of penetratin
Schaschke, Biol. Chem. 338(), 2002
On the size of the active site in proteases. I. Papain.
Schechter I, Berger A., Biochem. Biophys. Res. Commun. 27(2), 1967
PMID: 6035483
Activity-based proteomics: enzymatic activity profiling in complex proteomes.
Schmidinger H, Hermetter A, Birner-Gruenberger R., Amino Acids 30(4), 2006
PMID: 16773240
Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors.
Turk D, Podobnik M, Popovic T, Katunuma N, Bode W, Huber R, Turk V., Biochemistry 34(14), 1995
PMID: 7718586
Papain-like lysosomal cysteine proteases and their inhibitors: drug discovery targets?
Turk, Biochem. Soc. Symp. 70(), 2003
Development of an isotope-coded activity-based probe for the quantitative profiling of cysteine proteases.
van Swieten PF, Maehr R, van den Nieuwendijk AM, Kessler BM, Reich M, Wong CS, Kalbacher H, Leeuwenburgh MA, Driessen C, van der Marel GA, Ploegh HL, Overkleeft HS., Bioorg. Med. Chem. Lett. 14(12), 2004
PMID: 15149659
Cysteine protease inhibitors produced by the industrial koji mold, Aspergillus oryzae O-1018
Yamada, Biosci. Biotechnol. Biochem. 62(), 1998
Structural basis for development of cathepsin B-specific noncovalent-type inhibitor: crystal structure of cathepsin B-E64c complex.
Yamamoto A, Tomoo K, Matsugi K, Hara T, In Y, Murata M, Kitamura K, Ishida T., Biochim. Biophys. Acta 1597(2), 2002
PMID: 12044902
Crystal structure of human osteoclast cathepsin K complex with E-64.
Zhao B, Janson CA, Amegadzie BY, D'Alessio K, Griffin C, Hanning CR, Jones C, Kurdyla J, McQueney M, Qiu X, Smith WW, Abdel-Meguid SS., Nat. Struct. Biol. 4(2), 1997
PMID: 9033588

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 17339064
PubMed | Europe PMC

Search this title in

Google Scholar